Taro Pharmaceutical Industries (NYSE:TARO – Get Rating) was upgraded by investment analysts at StockNews.com from a “hold” rating to a “buy” rating in a report issued on Sunday. Taro Pharmaceutical Industries Stock Performance Shares of TARO stock opened at $29.39 on Friday. Taro Pharmaceutical Industries has a one year low of $22.89 and a one […]
Murchinson Ltd. trimmed its position in shares of Taro Pharmaceutical Industries Ltd. (NYSE:TARO – Get Rating) by 39.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 105,914 shares of the company’s stock after selling 69,606 shares during the period. Taro Pharmaceutical […]
StockNews.com lowered shares of Taro Pharmaceutical Industries (NYSE:TARO – Get Rating) from a buy rating to a hold rating in a research report report published on Saturday. Separately, HC Wainwright dropped their price objective on shares of Taro Pharmaceutical Industries from $54.00 to $35.00 and set a buy rating on the stock in a research […]
StockNews.com lowered shares of Taro Pharmaceutical Industries (NYSE:TARO – Get Rating) from a buy rating to a hold rating in a research report sent to investors on Wednesday. Separately, HC Wainwright dropped their price target on Taro Pharmaceutical Industries from $54.00 to $35.00 and set a buy rating on the stock in a research report […]
StockNews.com upgraded shares of Taro Pharmaceutical Industries (NYSE:TARO – Get Rating) from a hold rating to a buy rating in a research report released on Tuesday morning. Separately, HC Wainwright reduced their target price on Taro Pharmaceutical Industries from $54.00 to $35.00 and set a buy rating on the stock in a report on Wednesday, […]